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ABSTRACT
Objective To investigate whether exercise- based cardiac 
rehabilitation services continued during the COVID-19 
pandemic and how technology has been used to deliver 
home- based cardiac rehabilitation.
Design A mixed methods survey including questions 
about exercise- based cardiac rehabilitation service 
provision, programme diversity, patient complexity, 
technology use, barriers to using technology, and safety.
Setting International survey of exercise- based cardiac 
rehabilitation programmes.
Participants Healthcare professionals working in exercise- 
based cardiac rehabilitation programmes worldwide.
Main outcome measures The proportion of programmes 
that continued providing exercise- based cardiac 
rehabilitation and which technologies had been used to 
deliver home- based cardiac rehabilitation.
Results Three hundred and thirty eligible responses were 
received; 89.7% were from the UK. Approximately half 
(49.3%) of respondents reported that cardiac rehabilitation 
programmes were suspended due to COVID-19. Of 
programmes that continued, 25.8% used technology before 
the COVID-19 pandemic. Programmes typically started 
using technology within 19 days of COVID-19 becoming 
a pandemic. 48.8% did not provide cardiac rehabilitation 
to high- risk patients, telephone was most commonly used 
to deliver cardiac rehabilitation, and some centres used 
sophisticated technology such as teleconferencing.
Conclusions The rapid adoption of technology into standard 
practice is promising and may improve access to, and 
participation in, exercise- based cardiac rehabilitation beyond 
COVID-19. However, the exclusion of certain patient groups 
and programme suspension could worsen clinical symptoms 
and well- being, and increase hospital admissions. Refinement 
of current practices, with a focus on improving inclusivity and 
addressing safety concerns around exercise support to high- 
risk patients, may be needed.
INTRODUCTION
Cardiac rehabilitation (CR) is a comprehen-
sive programme of secondary prevention 
interventions for patients with heart disease, 
encompassing support for psychosocial health, 
medical risk management and cardiovascular 
risk factor modification, including exercise 
training.1 Exercise- based CR reduces cardio-
vascular deaths and recurrent myocardial 
infarction within 10 years and hospital admis-
sions within 2 years, and improves health- 
related quality of life.2–5 Despite these benefits, 
only 49% (n=141 648) of eligible UK patients 
enrolled to a CR programme between 2012 and 
2015.6 Increasing uptake to 65% could lead 
to 21 000 fewer hospital admissions and 8500 
fewer deaths over 10 years.7 In response, NHS 
England set an ambitious target to increase CR 
uptake to 85% by 2029.8
COVID-19 is spread by a highly contagious 
virus. As of September 2020, it has infected 
26 121 999 and has led to the death of 864 618 
Strengths and limitations of this study
 ► This is the first international report on the effect that 
COVID-19 restrictions have had on exercise- based 
cardiac rehabilitation.
 ► We report data from 330 cardiac rehabilitation 
healthcare professionals around the world, although 
the majority of data were from the UK.
 ► Our mixed methods survey enabled us to investigate 
how technology has been used to deliver exercise- 
based cardiac rehabilitation as well the barriers to 
using technology.
 ► Respondents were only able to complete the survey 
once, but we could have received more than one re-
sponse from professionals working in a single cardi-
ac rehabilitation programme.
 ► Our data could be used to inform future research 
agendas, international healthcare policy and local 
healthcare decision making.
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people worldwide.9 The rapid spread of COVID-19 infec-
tions resulted in governments imposing restrictions on 
face- to- face human contact.10 Numerous ‘non- essential’ 
healthcare services were suspended and patient atten-
dance to continuing services has decreased due to fear 
of contracting COVID-19.11 12 The COVID-19 pandemic 
may therefore undermine efforts to increase uptake to 
exercise- based CR.
Before COVID-19, expanding the availability of home- 
based programmes was recommended to try and increase 
participation in exercise- based CR.13 Yet, in 2019, 8.8% of 
UK CR patients participated in home- based programmes.14 
This is partly due to a lack of capacity within existing face- 
to- face services to offer home- based programmes.15 The 
recent suspension of face- to- face healthcare services, 
due to COVID-19, may have led to programmes rapidly 
adopting home- based, technology- facilitated services. 
Data from urgent and non- urgent care centres in the USA 
reported that teleconferencing consultations increased 
from 82 on 4 March 2020 to 1336 on 19 March 2020.16 
If a similar rate of technology adoption occurred in CR, 
this could have helped to maintain patient participation. 
These methods could also be adopted in future standard 
practice to increase accessibility and subsequent uptake 
to CR programmes.
The aim of this mixed methods survey, conducted in 
collaboration with the British Association for Cardiovas-
cular Prevention and Rehabilitation (BACPR), was to 
investigate whether exercise- based CR services continued 
during the COVID-19 pandemic. We also evaluated 
whether technology was used to deliver exercise- based 
CR, and the professional experiences of this technology, 
during the COVID-19 pandemic.
MATERIALS AND METHODS
Survey development
The methods and results are reported in conjunction 
with the Checklist for Reporting Results of Internet E- Sur-
veys (online supplemental appendix 1).17 This volun-
tary, cross- sectional, international, open survey, targeted 
at a convenience sample of healthcare professionals 
in exercise- based CR, was developed by SN and AFO. 
The broad topic of questions relating to the COVID-19 
pandemic included the following:
 ► If and how CR services were provided.
 ► The demographics and medical complexity of patients 
accessing CR services.
 ► How technology was used to undertake patient assess-
ments and deliver the exercise component of CR.
 ► The barriers encountered when using technology to 
deliver the exercise component of CR.
The survey was reviewed by the members of the 
BACPR elected council prior to ethical approval and 
was amended accordingly. The BACPR council includes 
physicians, nurses, physiotherapists, exercise physiol-
ogists, exercise instructors, psychologists, dietitians 
and occupational therapists. The resulting 35- item 
questionnaire was uploaded to the Qualtrics XM online 
survey platform (Provo, Utah, USA). Qualtrics has ISO/
IEC 27001 security certification. The automated data-
base was password- protected and stored on secure Qual-
trics and Sheffield Hallam University servers. The survey 
was presented across 21 pages, including background 
information and consent. There were 22 tick box items 
(19 mandatory), 7 mandatory numerical responses, 3 
non- mandatory sliding bar responses, 2 non- mandatory 
free- text responses and 1 mandatory date entry response. 
Four questions also permitted free- text responses under 
the option ‘other’. Response validation was used on 
all questions, where appropriate. Survey progress was 
displayed on each page. Participants did not have a 
completeness check/review option at the end of the 
survey. Participants were only able to visit the website 
once from the same IP (internet protocol) address and 
had 7 days to complete the survey once started. The 
functionality of the survey was tested by SN, AFO, SD, 
SH and AC. The final version of the online survey can 
be found in Appendixonline supplemental appendix 
2), was given institutional ethical approval by Sheffield 
Hallam University (ID: ER24303491), on the 29th May 
2020. All participants provided informed consent., and 
all study procedures were carried out following the rules 
of the Declaration of Helsinki of 1975 (https://www. 
wma. net/ what- we- do/ medical- ethics/ declaration- of- 
helsinki/), revised in 2013
Patient and public involvement
Patients and/or the public were not involved in the 
design, or conduct, or reporting or dissemination plans 
of this research.
Survey dissemination
On 2 June 2020, a recruitment email was sent to BACPR 
members; 746 healthcare professionals and academ-
icsworking in CR. This was repeated on 25 June 2020. 
The survey was also promoted on social media platforms 
(online supplemental appendix 3). A link to the survey 
was not posted on any website. The survey closed at 12:00 
on 31 July 2020. There were no incentives offered for 
participation.
Quantitative data analysis
Categorical data are reported as the number of responses, 
expressed as a percentage (%) of the respondents to each 
question. Continuous data are reported as median, with 
minimum and maximum values. Responses were reported 
for the full cohort and by the phase of CR that the respon-
dents worked in. Phase I was defined as the inpatient 
stage, phase II as the early discharge phase, phase III as a 
clinically supervised outpatient programme and phase IV 
as long- term physical activity maintenance. The number 
of responses to each question varied and is detailed in 
tables 1 and 2 and online supplemental appendix 4. Tests 
of statistical significance were not conducted.
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Qualitative data analysis
Free- text answers were exported into NVivo V.11 software 
for thematic analysis. Answers were coded inductively. 
The resulting coding framework was then reviewed to 
identify patterns and themes in the data. Similar codes 
were grouped to form lower order themes, which were 
then grouped into higher order themes. Each theme was 
given a descriptive explanation with illustrative quotes.
RESULTS
Responses
Four hundred and seven visits to the survey site were 
recorded. Seventy- seven (18.9%) did not progress past 
the study information and consent page (81.1% partic-
ipation rate). Three hundred and thirty responses 
were analysed, 296 (89.7%) of which were from the 
UK. The remaining responses were from Japan (n=8, 
2.4%), Australia (n=4, 1.2%), the USA (n=4, 1.2%), 
Ireland (n=4, 1.2%), Gibraltar (n=2, 0.6%), India (n=2, 
0.6%), South Africa (n=2, 0.6%), Spain (n=2, 0.6%), 
Table 1 Provision of cardiac rehabilitation services during the COVID-19 pandemic, displayed as n (%)
All Phase I Phase II Phase III Phase IV
Service status n=330 n=14 n=29 n=164 n=123
  Service able to see as many patients 
as usual
44 (13.3) 2 (14.3) 6 (20.7) 30 (18.3) 6 (4.9)
  Service able to see fewer patients 
than usual
123 (37.3) 6 (42.9) 12 (41.4) 77 (47.0) 28 (22.8)
  Service suspended (%) 163 (49.4) 7 (42.9) 11 (37.9) 57 (34.8) 89 (72.4)
Patients accessing cardiac 
rehabilitation
n=161 n=8 n=17 n=102 n=34
  No patients are accessing the service 18 (11.2) 2 (25.0) 3 (17.6) 9 (8.8) 4 (11.8)
  Fewer patients are accessing the 
service
111 (68.9) 5 (62.5) 13 (76.5) 65 (63.7) 28 (82.4)
  Same number of patients are 
accessing the service
32 (19.9) 1 (12.5) 1 (5.9) 28 (27.5) 2 (5.9)
Diversity of cardiac rehabilitation n=151 n=7 n=16 n=95 n=33
  Patient population is less diverse 
than before COVID-19
22 (14.6) 3 (42.9) 1 (6.25) 13 (13.7) 5 (15.2)
  Patient population is as diverse as it 
was before COVID-19
122 (80.8) 4 (57.1) 15 (93.8) 78 (82.1) 25 (75.8)
  Patient population is more diverse 
than before COVID-19
7 (4.6) 0 (0.0) 0 (0.0) 4 (4.2) 3 (9.1)
  Patient population is younger than 
before COVID-19
6 (4.1) 0 (0.0) 2 (13.3) 2 (2.2) 2 (6.3)
  Patient population is similar to what it 
was before COVID-19
135 (92.5) 5 (71.4) 12 (80.0) 89 (96.7) 29 (90.6)
  Patient population is older than 
before COVID-19
5 (3.4) 2 (28.6) 1 (6.7) 1 (1.1) 1 (3.1)
  Estimated percentage of patients in 
the last 7 days that were >65 years
70.0 (0.0–100.0) 75.0 (60.0–85.0) 67.0 (38.0–100.0) 64.5 (0.0–100.0) 80.0 (0.0–100.0)
  Proportion of female participation is 
smaller
11 (0.8) 1 (16.7) 0 (0.0) 8 (9.4) 2 (6.9)
  Proportion of female participation is 
the same
113 (83.7) 4 (66.7) 14 (93.3) 69 (81.2) 26 (89.7)
  Proportion of female participation is 
larger
11 (0.8) 1 (16.7) 1 (6.7) 8 (9.4) 1 (3.4)
  Proportion of male participation is 
smaller
6 (4.4) 1 (16.7) 1 (6.7) 2 (2.4) 2 (7.0)
  Proportion of male participation is 
the same
123 (91.1) 4 (66.7) 14 (93.3) 79 (92.9) 26 (89.7)
  Proportion of male participation is 
larger
6 (4.4) 1 (16.7) 0 (0.0) 4 (4.7) 1 (3.4)
  Estimated percentage of patients in 
the last 7 days were female
30.0 (0.0–80.0) 40.0 (10.0–70.0) 30.0 (1.0–57.0) 30.0 (0.0–80.0) 40.0 (1.0–73.0)
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the Bailiwick of Guernsey (n=1, 0.3%), Canada (n=1, 
0.3%), the Isle of Man (n=1, 0.3%) and Kuwait (n=1, 
0.3%).
Service provision during the COVID-19 pandemic
At the time of responding, 163 (49.3%) CR programmes 
had been suspended due to COVID-19 (table 1). The 
proportions of UK (n=147, 49.7%) and non- UK (n=16, 
47.1%) services that had been suspended were similar. 
Phase IV programmes were most likely to have suspended 
all activities (n=89, 72.4%; table 1). The remaining ques-
tions in the survey were applicable to a maximum of 167 
respondents. The number of responses to each question 
can be seen in table 1 and online supplemental appendix 
4.
Following COVID-19 restrictions, 32 (19.9%) 
programmes reported that the same volume of patients 
were choosing to access their service (table 1). Most 
programmes reported that either fewer patients (n=111, 
68.9%) or no patients (n=18, 11.2%) were choosing to 
access their service (table 1). Programmes believed that 
patients enrolling in CR were either as demographically 
as diverse (n=122, 80.8%) or more diverse than normal 
(n=7, 4.6%; table 1). UK CR programmes also estimated 
that 90.4% (0.0%–100.0%) of patients seen in the last 
7 days were ‘White British’. Most CR programmes (92.5%) 
reported that the age of participants was similar to 
normal, with 70% (0.0%–100.0%) of patients enrolling in 
CR >65 years of age (table 1). Programmes also reported 
that the sex of patients participating in CR was propor-
tionally similar to normal. Female participation in CR was 
estimated at 30% (0.0%–80%; table 1).
Technology adoption
Figure 1 shows the increase in adoption of technology 
over time. The earliest date that a programme reported 
using technology was 10 January 2010. The latest was on 
20 June 2020. Thirty- three (25.8%) used technology to 
deliver exercise- based CR before COVID-19 was declared 
a pandemic by the WHO.18 The median date of tech-
nology adoption was 30 March 2020. There were notable 
increases in technology adoption. The first coincided 
with the release of the UK’s NHS Long Term Plan.8 
The second, more rapid increase, coincides with the 
COVID-19 pandemic.18
Technology use in patient assessment
The most commonly used technology to conduct patient 
assessment was telephone (n=113, 85.0%; figure 2). Thir-
ty- two (24.1%) programmes reported that they were not 
assessing or estimating functional capacity. Practitioners 
mostly relied on patient self- reported fitness to estimate 
functional capacity (n=92, 69.2%). Some programmes 
estimated functional capacity by using a questionnaire 
(26.3%, n=35) or the patient’s own physical activity 
tracker (21.1%, n=28). One phase I (16.7%), two phase 
II (14.3%) and four phase IV (13.8%) CR programmes 
remotely supervised exercise testing (figure 2).
Technology use in physical activity and exercise prescription
Most services were able to provide physical activity 
advice (n=102, 82.9%). Seventy- two (58.5%) 
programmes also offered structured exercise 
training programmes. Telephone remained the most 
commonly used technology to facilitate the physical 
activity or exercise component of CR (n=86, 64.7%; 
figure 3). Prerecorded online videos (n=69, 51.9%) 
were also widely used, particularly among phase III 
programmes (n=54, 64.3%; figure 3). Most CR services 
were able to provide physical activity or structured 
exercise training to patients at low (n=117, 95.1%) 
and moderate (n=109, 88.6%) risk of exercise- induced 
cardiac events. Half (51.2%, n=63) were able to offer 
services to patients at high risk of exercise- induced 
cardiac events. Three (2.8%) programmes reported 
one adverse event resulting in minor injury while 
Table 2 Barriers to using technology in exercise- based cardiac rehabilitation, displayed as n (%)









Lack of patient confidence 93 (86.9) 2 (33.3) 8 (88.9) 60 (88.2) 23 (95.8)
Patients do not have access to computers/tablets/smart 
phone
86 (80.4) 2 (33.3) 4 (44.4) 61 (89.7) 19 (79.2)
Patients do not have an internet connection 73 (68.2) 2 (33.3) 6 (66.7) 48 (70.6) 17 (70.8)
Patients lack interest in receiving services using technology 65 (60.7) 1 (16.7) 5 (55.6) 44 (64.7) 15 (62.5)
Professionals are concerned about patient safety 43 (40.2) 0 (0.0) 3 (33.3) 34 (50.0) 6 (25.0)
Patients are concerned about safety 32 (29.9) 2 (33.3) 3 (33.3) 21 (30.9) 6 (25.0)
Internet security and patient confidentiality concerns 27 (25.2) 1 (16.7) 4 (44.4) 18 (25) 4 (16.7)
Professionals not confident delivering service using 
technology
24 (22.4) 0 (0.0) 2 (22.2) 19 (27.9) 3 (12.5)
Trusts/Health Boards do not support the delivery of health 
services using technology
16 (15.0) 1 (16.7) 0 (0.0) 14 (20.6) 1 (4.2)
No barriers 2 (1.9) 1 (11.1) 0 (0.0) 1 (1.5) 0 (0.0)
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using technology to deliver the exercise component 
of CR (three events in total). There were no reports 
of life- changing injury or death.
Barriers to using technology
The number of responses to each question about 
barriers to using technology is shown in table 2. 
Respondents were asked to state any barriers that 
they encountered when using technology. Only two 
(1.9%) programmes reported ‘no barriers’ (table 2). 
Most (n=93, 86.9%) encountered a ‘lack of patient 
confidence’ with technology (table 2). Qualitative 
analysis of the barriers to using technology fell into 
two categories: logistical and organisational barriers, 
and patient- related barriers. Logistical and organ-
isational barriers were largely a result of healthcare 
organisations being unprepared and not familiar with 
Figure 1 Data showing the use of technology to deliver exercise- based cardiac rehabilitation between January 2010 and June 
2020. Black bars indicate how many programmes started using their chosen technology on a given date. The grey area shows 
the cumulative number of cardiac rehabilitation programmes using technology.
Figure 2 Types of technology used to undertake baseline assessments.
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using online healthcare delivery. Onerous governance 
processes and delayed access to the necessary infor-
mation technology equipment were also described. 
Patient- related barriers were associated with commu-
nication (either language or understanding) and 
concerns that patients were either over- reporting 
their activity or not following the advice provided.
Practitioner experiences
Qualitative analysis of free- text answers to the final ques-
tion allowing ‘Any other comments’ resulted in the iden-
tification of three higher order themes: (1) impact on 
patient experience, (2) challenges for the staff and (3) 
implications for future delivery.
Impact on patient experience
Survey respondents varied in their views about the impact 
on patient engagement and experience. Technology 
was acknowledged as a valuable means of connecting 
patients with CR staff, but a small number of respondents 
also highlighted that it was harder to establish rapport 
this way. One participant reported a decline in patients’ 
fitness outcomes, while another claimed that patients 
exercised harder at home without peers to distract them. 
More commonly, participants reported that, regardless of 
the perceived benefits of remote delivery, it was difficult 
to replicate the social benefits associated with group exer-
cise delivery:
The lack of contact with other patients means the pa-
tients miss out on the social and emotional support 
from each other.
Challenges for professionals
Survey participants cited a range of challenges to adop-
tion of technology, including the limitations of existing 
platforms, such as smart device applications for CR. 
These were described as lacking patient- centred or 
motivational content and being time- consuming to use. 
Participants reported further difficulties associated with 
COVID-19- related staff redeployment or illness, and reit-
erated barriers such as lack of access to technology and 
organisational delays caused by information technology 
and governance restrictions.
A large number of comments described concerns 
relating to practitioners’ inability to observe patients, 
limiting safe and accurate assessment of functional 
capacity. This had resulted in a more cautious approach, 
with respondents reporting that they prescribed only 
gentle or low- level exercise:
Our main concern has been the difficulty of not be-
ing able to complete functional capacity assessments, 
we have therefore recommended patients exercise at 
a lower level than we normally would.
Implications for future delivery
Many respondents were optimistic about continuing to 
incorporate technology in future CR delivery. Never-
theless, it was generally recognised that delivery should 
be flexible. Exercise programmes should be tailored to 
individual needs and risk levels and patients should be 
provided with a range of options for engaging with CR, 
including both face- to- face contact with CR staff and 
online/home- based exercise.
Several comments indicated opportunities for improve-
ment in the technology available, with one participant 
suggesting that current formats were driven by National 
Audit of Cardiac Rehabilitation (NACR) data require-
ments as opposed to patient needs. Another respondent 
Figure 3 Types of technology used to deliver the exercise component of cardiac rehabilitation.
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called for further research to inform more confident 
remote exercise prescription:
Still feel face to face assessment is superior for 
more frail patients …and for higher risk patients… 
Nevertheless, I am gaining more confidence in re-
mote assessment, and would be reassured further by 
some research to demonstrate its safety and efficacy. 
I already know remote delivery has been shown to be 
safe and effective, but as far as I am aware this has 
been evidenced only when prescribed from face to 
face assessment.
Quantitatively, 94 (88.7%) programmes believed 
that technology should be available for patients in the 
future.
DISCUSSION
To our knowledge, this is the first study to quantitatively 
document the effect that restrictions, imposed due to 
COVID-19, had on exercise- based CR programmes. 
We found that nearly half of all programmes had been 
suspended and that most centres reported a reduction in 
patient engagement with services during the COVID-19 
pandemic. Practitioners reported that the age and sex 
of patients attending CR were similar to before the 
COVID-19 pandemic. Technology was rapidly adopted to 
deliver CR, with less sophisticated technology, such as the 
telephone, being most widely used. Higher risk patients 
were less likely to be offered remote CR using technology. 
Nearly all centres reported barriers to using technology to 
deliver CR. Finally, despite an openness to adopting tech-
nology by practitioners, there were concerns surrounding 
availability of and confidence in using technology. Quali-
tatively, patient assessment, less opportunity for socialisa-
tion and safety were highlighted.
Service provision
COVID-19 has resulted in many non- essential healthcare 
services being suspended. We have shown that this was 
true for half of exercise- based CR services. In 2019, 89 573 
patients accessed exercise- based CR in the UK14; there-
fore, a high proportion of cardiac patients may have been 
negatively affected by this widespread service disruption. 
Given that exercise- based CR improves quality of life4 19 
and reduces hospital admissions,3 suspension of services 
is likely to result in worsening clinical symptoms, well- 
being, and increased hospital admissions long term. This 
may place an increased burden on healthcare services in 
the coming months. Nevertheless, there was an increase 
in the use of technology in CR shortly after COVID-19 was 
declared a pandemic by the WHO.18 Comparing long- 
term patient outcomes from programmes that continued 
service provision with programmes that were unable to 
continue will help to determine the effectiveness of these 
changes.
Technology adoption and barriers
Recent editorials and reviews have suggested that 
COVID-19 could be a catalyst for large- scale changes 
in the way that CR is delivered.20 21 We found that most 
services started using technology to deliver exercise- 
based CR, at home, within 3 weeks of COVID-19 being 
declared a pandemic by the WHO18; only three services 
were providing face- to- face services. This suggests that the 
capacity of CR services to provide home- based rehabili-
tation programmes has rapidly increased. If maintained, 
subject to robust evidence, the potential for increased 
accessibility could positively influence participation in CR 
when face- to- face service has resumed.
Traditional modes of communication such as telephone 
were most commonly used. Surprisingly few services 
used teleconferencing, smart device applications and 
web- based systems. Healthcare professionals cited that 
patients often lacked confidence using equipment and/
or that patients did not have the required equipment for 
technology use. The number and the sociodemographic 
profile of patients for whom this was a genuine barrier are 
unclear. Others have reported that age may be a factor, 
with people aged 22–44 years most likely to use telecon-
ferencing facilities16 and people over 65 years being less 
likely to have a smart phone.22 This could warrant further 
investigation to address inequalities in the accessibility 
of technology- based provision of CR. Meanwhile, profes-
sionals’ concerns for patient safety (40.2%) and internet 
security (25.2%) were also likely to contribute to the low 
uptake of novel technology. Healthcare organisations 
being underprepared for the adoption of new technology 
may also play a role, although this was less frequently 
reported in quantitative analysis. ‘Top- down’ endorse-
ment of technology by health Trusts, Health Boards or 
healthcare providers may give healthcare professionals 
confidence in using technology.
Participation
Participation in CR continued despite COVID-19 restric-
tions. However, programmes were able to offer services 
to fewer patients and updake was reduced. Furthermore, 
UK programmes reported that ~90% of participants were 
‘White British’, which is proportionately higher than 
recently indicated (79%) in the 2019 NACR report.14 
Future research should investigate the direct impact of 
COVID-19 on minority group participation in exercise- 
based CR and explore how to increase their participation 
when CR is delivered using technology. Encouragingly, 
programmes reported that similar proportions of men 
and women and people over the age of 65 years engaged 
with CR compared with pre- COVID-19 participation.
Data from our survey showed that 41.5% of programmes 
were unable to provide exercise- based CR to patients at 
high risk of exercise- induced cardiac events. CR should 
be available to all eligible patients, irrespective of risk.1 
The development and refinement of future technology- 
based interventions should be inclusive of all risk levels. 
Qualitative comments highlighted concerns about using 
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technology to remotely deliver exercise- based CR for frail 
patients. Safety concerns were also a common feature 
in our quantitative analysis (table 2). The wide use of 
‘offline’ delivery modes such as telephone and prere-
corded videos identified in our survey limits the capacity 
to evaluate physiological information during exercise 
and the scope for practitioners to tailor advice to the 
individual. It may be perceived as unsafe for patients at 
high risk of an exercise- induced cardiac event, but not for 
lower risk patients. Overcoming these concerns, through 
robust evidence, may be an important step in negating 
future health inequalities.
Limitations
The high UK response rate to our survey (n=296, 89.7%) 
makes it likely that our findings are representative 
of CR in the UK. However, the response rate from CR 
programmes outside of the UK was low. The generalis-
ability of our findings outside of the UK may therefore 
be limited. Additionally, we aimed to recruit healthcare 
professionals rather than patients. Future research should 
investigate patient perceptions of using technology in CR 
so that a more complete understanding of barriers can 
be reported. We also asked study participants to report 
on whether they perceived that certain demographics of 
the patients engaging with their services had changed; 
therefore, we cannot exclude information bias. Finally, 
individual practitioners rather than centres were targeted 
to respond. Therefore, the risk of bias could have been 
increased by multiple practitioners from the same centre 
completing the survey.
CONCLUSIONS
Nearly half of all CR programmes have been suspended 
during COVID-19 restrictions. Technology was rapidly 
adopted by CR services, which may increase participation 
beyond COVID-19. However, higher risk patients may be 
disadvantaged by technology use, while people in the UK 
who are ‘White British’ may most likely benefit from it. 
Our findings indicate a role of technology in future CR 
delivery. There is a need for innovation in patient- centred, 
interactive technological resources that also foster confi-
dence among practitioners. Future research needs to 
investigate the longer term adoption of technology in 
CR following COVID-19 and its effects on participation, 
patient experience, and safety.
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